Immunovant Inc (IMVT) Hedge Fund & Institutional Holdings (Q2 2026)

IMVT ranks #2671 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

IMVT is a top-conviction position for Alpine Global Management, LLC — at 8.6% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in IMVT belongs to FMR LLC, but the position matters far more to Alpine Global Management, LLC, who has 8.6% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Two Seas Capital LP has added to its IMVT position for two straight quarters, increasing it by $76.3M to reach $155.8M today.

Assenagon Asset Management S.A. has trimmed its IMVT position for two straight quarters, cutting it by $4.5M while still holding $560.0K.

IMVT is down 5.6% today, but institutions show net buying of $222.2M this quarter — a divergence between today's price move and the underlying institutional flow.

IMVT reported a net loss of $505.6M in its latest fiscal year.

• Not yet profitable — net loss of $505.6M in the latest fiscal year
• Net income declined year over year, from -$413.8M to -$505.6M
• Operating cash flow was negative, using $407.3M in cash
• Current ratio of 9.09x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.12x equity — within a conventional range